-
公开(公告)号:WO03020880A2
公开(公告)日:2003-03-13
申请号:PCT/US0224546
申请日:2002-08-02
Applicant: ABBOTT LAB , BORHANI DAVID W , CALDERWOOD DAVID , DIXON RICHARD W , HIRST GAVIN C , HRNCIAR PETER , LOEW ANDREAS , LEUNG ADELAINE , RITTER KURT
Inventor: BORHANI DAVID W , CALDERWOOD DAVID , DIXON RICHARD W , HIRST GAVIN C , HRNCIAR PETER , LOEW ANDREAS , LEUNG ADELAINE , RITTER KURT
CPC classification number: C12N9/1205 , C07K2299/00
Abstract: The present invention relates to polypeptides which comprise the ligand binding domain of Lck, crystalline forms of these polypeptides, and the use of these crystalline forms to determine the three dimensional structure of the catalytic domain of Lck. The invention also relates to the use of the three dimensional structure of the Lck catalytic domain both alone, or in complex with inhibitors, in methods of designing and/or identifying potential inhibitors of Lck activity, for example, compounds which inhibit the binding of a native substrate to the Lck catalytic domain. The invention also relates to the use of the three dimensional structure of the Lck catalytic domain both alone, or in complex with inhibitors, in methods of designing and/or identifying potential selective inhibitors of Lck activity, for example, compounds which inhibit the binding of a native substrate to the Lck catalytic domain selectively.
Abstract translation: 本发明涉及包含Lck的配体结合结构域,这些多肽的结晶形式的多肽以及使用这些结晶形式来确定Lck的催化结构域的三维结构。 本发明还涉及单独或与抑制剂复合的Lck催化结构域的三维结构在设计和/或鉴定潜在的Lck活性抑制剂的方法中的用途,例如抑制 天然底物到Lck催化结构域。 本发明还涉及单独或与抑制剂复合的Lck催化结构域的三维结构在设计和/或鉴定潜在的Lck活性选择性抑制剂的方法中的应用,例如抑制 选择性地将天然底物连接到Lck催化结构域。
-
公开(公告)号:WO2008005368A2
公开(公告)日:2008-01-10
申请号:PCT/US2007015192
申请日:2007-06-29
Applicant: ABBOTT LAB , BETSCHMANN PATRICK , CARROLL WILLIAM A , ERICSSON ANNA M , FIX-STENZEL SHANNON R , FRIEDMAN MICHAEL , HIRST GAVIN C , JOSEPHSOHN NATHAN S , LI BIQIN , PEREZ-MEDRANO ARTURO , MORYTKO MICHAEL J , RAFFERTY PAUL , CHEN HAIPENG
Inventor: BETSCHMANN PATRICK , CARROLL WILLIAM A , ERICSSON ANNA M , FIX-STENZEL SHANNON R , FRIEDMAN MICHAEL , HIRST GAVIN C , JOSEPHSOHN NATHAN S , LI BIQIN , PEREZ-MEDRANO ARTURO , MORYTKO MICHAEL J , RAFFERTY PAUL , CHEN HAIPENG
IPC: A61K31/496
CPC classification number: C07D241/04 , C07D241/36 , C07D295/215 , C07D401/06 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D403/12 , C07D403/14 , C07D405/06 , C07D405/12 , C07D405/14 , C07D409/06 , C07D409/12 , C07D409/14 , C07D413/04 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04 , C07D498/04 , C07D513/04
Abstract: Novel compounds of Formula (I) or pharmaceutically acceptable salts thereof, metabolites thereof, isomers thereof, enantiomers thereof or prodrugs thereof of Formula (I), wherein the substituents are as defined herein, which are useful as therapeutic agents.
Abstract translation: 式(I)的新型化合物或其药学上可接受的盐,其代谢物,其异构体,其对映异构体或其前体药物,其中取代基如本文所定义,其可用作治疗剂。
-
公开(公告)号:WO2007028051A3
公开(公告)日:2007-11-01
申请号:PCT/US2006034275
申请日:2006-09-01
Applicant: ABBOTT LAB , BRIENLINGER ERIC C , CALDERWOOD DAVID J , FRANK KRISTINE E , BETSCHMANN PATRICK , HIRST GAVIN C , MORYTKO MICHAEL J , DIXON RICHARD W
Inventor: BREINLINGER ERIC C , CALDERWOOD DAVID J , FRANK KRISTINE E , BETSCHMANN PATRICK , HIRST GAVIN C , MORYTKO MICHAEL J , DIXON RICHARD W
IPC: A01N43/50
CPC classification number: C07D487/04
Abstract: The present invention is directed to novel imidazopyrazine and imidazopyrimidine compounds of formula (I), wherein the variables are as defined herein. The compounds of formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.
Abstract translation: 本发明涉及式(I)的新咪唑并吡嗪和咪唑并嘧啶化合物,其中变量如本文所定义。 式(I)化合物可用作激酶抑制剂,因此可用于治疗某些病症和疾病,特别是炎性病症和疾病以及增殖性病症和病症,例如癌症。
-
公开(公告)号:EP1496910A4
公开(公告)日:2006-03-29
申请号:EP03718039
申请日:2003-03-21
Applicant: ABBOTT LAB
Inventor: HIRST GAVIN C , ARNOLD LEE D , BURCHAT ANDREW , WISHART NEIL , CALDERWOOD DAVID , WADA CAROL K , MICHAELIDES MICHAEL R , JI ZHIQIN , MUCKEY MELANIE
IPC: A61K31/519 , A61P1/04 , A61P1/16 , A61P3/10 , A61P5/14 , A61P7/00 , A61P7/06 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/06 , A61P13/12 , A61P15/08 , A61P17/02 , A61P17/06 , A61P19/02 , A61P27/02 , A61P27/06 , A61P29/00 , A61P31/04 , A61P31/12 , A61P31/18 , A61P31/22 , A61P33/02 , A61P35/00 , A61P35/02 , A61P37/02 , A61P37/06 , A61P43/00 , C07D413/04 , C07D487/04 , C07D491/04 , C07D491/048 , C07D498/04
CPC classification number: C07D487/04 , C07D491/04
-
公开(公告)号:EP1928237A4
公开(公告)日:2011-03-09
申请号:EP06824879
申请日:2006-09-01
Applicant: ABBOTT LAB
Inventor: BREINLINGER ERIC C , CALDERWOOD DAVID J , FRANK KRISTINE E , BETSCHMANN PATRICK , HIRST GAVIN C , MORYTKO MICHAEL J , DIXON RICHARD W
IPC: A01N43/50
CPC classification number: C07D487/04
-
公开(公告)号:DK1648905T3
公开(公告)日:2009-03-30
申请号:DK04779180
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , CURTIN MICHAEL L , DAVIDSEN STEVEN K , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MICHAELIDES MICHAEL R , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/04 , C07D498/04
Abstract: Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
-
公开(公告)号:AU2003222055A1
公开(公告)日:2003-10-08
申请号:AU2003222055
申请日:2003-03-21
Applicant: ABBOTT LAB
Inventor: HIRST GAVIN C , ARNOLD LEE D , BURCHAT ANDREW , WISHART NEIL , CALDERWOOD DAVID , WADA CAROL K , MICHAELIDES MICHAEL R , JI ZHIQIN , MUCKEY MELANIE
IPC: A61K31/519 , A61P1/04 , A61P1/16 , A61P3/10 , A61P5/14 , A61P7/00 , A61P7/06 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/06 , A61P13/12 , A61P15/08 , A61P17/02 , A61P17/06 , A61P19/02 , A61P27/02 , A61P27/06 , A61P29/00 , A61P31/04 , A61P31/12 , A61P31/18 , A61P31/22 , A61P33/02 , A61P35/00 , A61P35/02 , A61P37/02 , A61P37/06 , A61P43/00 , C07D413/04 , C07D487/04 , C07D491/04 , C07D491/048 , C07D498/04 , C07D491/00 , C07D487/02 , C07D473/00 , C07D471/00 , C07D487/00
Abstract: The present application is directed to pyrazolopyrimidine and furopyrimnidine analogs of the formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
-
公开(公告)号:CA2477651A1
公开(公告)日:2003-10-02
申请号:CA2477651
申请日:2003-03-21
Applicant: ABBOTT LAB
Inventor: BURCHAT ANDREW , ARNOLD LEE D , WADA CAROL K , HIRST GAVIN C , WISHART NEIL , CALDERWOOD DAVID , MICHAELIDES MICHAEL R , MUCKEY MELANIE , JI ZHIQIN
IPC: A61K31/519 , A61P1/04 , A61P1/16 , A61P3/10 , A61P5/14 , A61P7/00 , A61P7/06 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/06 , A61P13/12 , A61P15/08 , A61P17/02 , A61P17/06 , A61P19/02 , A61P27/02 , A61P27/06 , A61P29/00 , A61P31/04 , A61P31/12 , A61P31/18 , A61P31/22 , A61P33/02 , A61P35/00 , A61P35/02 , A61P37/02 , A61P37/06 , A61P43/00 , C07D413/04 , C07D487/04 , C07D491/04 , C07D491/048 , C07D498/04 , C07D473/00 , C07D491/00
Abstract: The present application is directed to pyrazolopyrimidine and furopyrimidine analogs of the formula (I), wherein the substituents are as defined herein, which are useful as kinase inhibitors.
-
公开(公告)号:PT1648905E
公开(公告)日:2009-04-08
申请号:PT04779180
申请日:2004-07-26
Applicant: ABBOTT LAB
Inventor: DAVIDSEN STEVEN K , CURTIN MICHAEL L , MICHAELIDES MICHAEL R , BETSCHMANN PATRICK , BURCHAT ANDREW F , CALDERWOOD DAVID J , DAVIS HEATHER M , FREY ROBIN R , HEYMAN HOWARD R , HIRST GAVIN C , HRNCIAR PETER , MUCKEY MELANIE A , RAFFERTY PAUL , WADA CAROL K
IPC: C07D495/04 , A61K31/4353 , A61K31/4355 , A61K31/4365 , A61P35/00 , C07D491/00 , C07D491/04 , C07D495/00 , C07D498/00 , C07D498/04
-
公开(公告)号:PL373649A1
公开(公告)日:2005-09-05
申请号:PL37364903
申请日:2003-03-21
Applicant: ABBOTT LAB
Inventor: HIRST GAVIN C , ARNOLD LEE D , BURCHAT ANDREW , WISHART NEIL , CALDERWOOD DAVID , WADA CAROL K , MICHAELIDES MICHAEL R , JI ZHIQIN , MUCKEY MELANIE
IPC: A61K31/519 , A61P1/04 , A61P1/16 , A61P3/10 , A61P5/14 , A61P7/00 , A61P7/06 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/06 , A61P13/12 , A61P15/08 , A61P17/02 , A61P17/06 , A61P19/02 , A61P27/02 , A61P27/06 , A61P29/00 , A61P31/04 , A61P31/12 , A61P31/18 , A61P31/22 , A61P33/02 , A61P35/00 , A61P35/02 , A61P37/02 , A61P37/06 , A61P43/00 , C07D413/04 , C07D487/04 , C07D491/04 , C07D491/048 , C07D498/04 , C07D487/02
Abstract: The present application is directed to pyrazolopyrimidine and furopyrimnidine analogs of the formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
-
-
-
-
-
-
-
-
-